-
Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Oxford Immunotec Global
Company Profile
Quarter (USD) | Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 160.72 mm | 160.72 mm | 160.72 mm | 160.72 mm | 160.72 mm | 160.72 mm |
Cash burn (monthly) | 1.62 mm | 2.22 mm | (no burn) | 1.21 mm | 1.20 mm | 989.83 k |
Cash used (since last report) | 84.87 mm | 116.24 mm | n/a | 63.54 mm | 62.81 mm | 51.77 mm |
Cash remaining | 75.85 mm | 44.48 mm | n/a | 97.18 mm | 97.91 mm | 108.95 mm |
Runway (months of cash) | 46.7 | 20.0 | n/a | 80.0 | 81.5 | 110.1 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 29.15 mm |
Total shares | 1.33 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Integrated Core Strategies | 1.33 mm | $29.15 mm |